Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Pharmexa is a leading biotech company in the field of active immunotherapy and vaccines for the treatment of cancer, serious chronic and infectious diseases. The company has been listed on the Copenhagen Stock Exchange since 2000. The Pharmexa group consists of GemVax AS, a Norwegian subsidiary, developing peptide vaccines for cancer and Pharmexa-Epimmune, a US subsidiary, focusing on T cell epitope-based vaccines for cancer and infectious diseases. ( www.pharmexa.com )
Pharmexa
Piper Jaffray Ltd. – Dr. Richard Parks & Dr. Sally Bennett 18 King William Street
London EC4N 7US
United Kingdom
Tel: +45 8922 2864